A powerful consortium of some of the world’s most recognized names in higher education, health care, real estate and life sciences is collaborating to create a center for advanced biological innovation and manufacturing.
The $50 million first-of-its-kind center, which will be set up as an independent nonprofit, will explore regenerative therapies in a cross-sector environment that aims to shorten the gap between research, biomanufacturing and clinical application.
Often, a funded biotech startup will cultivate an idea, but have to wait up to 18 months or longer to manufacture a product. The as-yet-unnamed center aims to cut the backlog and bottleneck by providing manufacturing space at “favorable pricing,” with “pharma-grade” GMP manufacturing cleanrooms, according to a press release. The center will also provide a platform for workforce development and training.
